# Buspirone for Anxiety in Autistic Youth

> **NCT07439042** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Anxiety
- Autism Spectrum Disorder

## Interventions

- **DRUG:** buspirone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07439042
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-02
- **Final completion:** 2029-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439042, "Buspirone for Anxiety in Autistic Youth". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07439042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*